These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Vioxx doctors wooed by Merck are now its foes. Tesoriero HW Wall St J (East Ed); 2006 Mar; ():B1, B3. PubMed ID: 16578911 [No Abstract] [Full Text] [Related]
3. [Really only Vioxx?]. Heinzl S Med Monatsschr Pharm; 2004 Nov; 27(11):361. PubMed ID: 15566229 [No Abstract] [Full Text] [Related]
4. How to avoid another 'Vioxx'. Frantz S Nat Rev Drug Discov; 2005 Jan; 4(1):5-7. PubMed ID: 15690595 [No Abstract] [Full Text] [Related]
5. [General practice study of therapy of acute pain. Patients prefer cox-2 inhibitors]. MMW Fortschr Med; 2004 May; 146(21):61. PubMed ID: 15373091 [No Abstract] [Full Text] [Related]
6. Discontinuation of Vioxx. Nutt DJ Lancet; 2005 Jan 1-7; 365(9453):28. PubMed ID: 15639676 [No Abstract] [Full Text] [Related]
7. Lessons to be learned from the Vioxx debacle. Beller GA J Nucl Cardiol; 2005; 12(1):1-2. PubMed ID: 15682357 [No Abstract] [Full Text] [Related]
8. The lessons of Vioxx--drug safety and sales. Waxman HA N Engl J Med; 2005 Jun; 352(25):2576-8. PubMed ID: 15972862 [No Abstract] [Full Text] [Related]
9. The story of Vioxx--no pain and a lot of gain: ethical concerns regarding conduct of the pharmaceutical industry. Cahana A; Mauron A J Anesth; 2006; 20(4):348-51. PubMed ID: 17072707 [No Abstract] [Full Text] [Related]
10. The Vioxx fallout. Palmer K Minn Med; 2005 Mar; 88(3):26-30. PubMed ID: 15852592 [No Abstract] [Full Text] [Related]
11. Vioxx, the implosion of Merck, and aftershocks at the FDA. Horton R Lancet; 2004 Dec 4-10; 364(9450):1995-6. PubMed ID: 15582041 [No Abstract] [Full Text] [Related]
12. The problem of new uses. Eisenberg RS Yale J Health Policy Law Ethics; 2005; 5(2):717-39. PubMed ID: 16052897 [No Abstract] [Full Text] [Related]